Business Review for the Nine Months Ended September 30, 2010

• Nine-month sales up 4.3%* (5.5%* excluding the H1N1 impact)
• Continued deterioration of the healthcare environment in Western Europe and North America
• Very strong growth drivers*
  • “Emerging 7” up 26%, excluding the H1N1 impact
  • Clinical microbiology up 6.3%
  • VIDAS® up 8.8%
  • Industrial applications up 8%
• Confirmation of the 2010 target for operating margin before non-recurring items

Download Full Press Release: